TNNT3: Troponin T3, Fast Skeletal Type

Gene encoding the fast skeletal muscle troponin T isoform, critical for muscle contraction and implicated in distal arthrogryposis and nemaline myopathy.

Gene Information Card

Symbol TNNT3
Full Name Troponin T3, fast skeletal type
Gene Type protein-coding
Chromosomal Location 11p15.5
NCBI Gene ID 7140 ncbi.nlm.nih.gov/gene/7140
Ensembl ID ENSG00000130595
UniProt ID P45378
OMIM ID 600692
HGNC ID 11950
Aliases TnTf, AMCD2B, DA2B, FSSV, MGC126696, MGC126698

Description

TNNT3 encodes the fast skeletal muscle isoform of troponin T, a component of the troponin complex that regulates calcium-mediated muscle contraction. This isoform is expressed predominantly in fast-twitch skeletal muscle fibers. Mutations in TNNT3 are associated with distal arthrogryposis type 2B (DA2B) and nemaline myopathy. The gene spans approximately 18 kb on chromosome 11p15.5 and contains 14 exons. Alternative splicing generates multiple isoforms with distinct functional properties.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Distal Arthrogryposis Type 2B (DA2B) Missense mutations in TNNT3 disrupt calcium sensitivity and cross-bridge cycling, leading to impaired muscle relaxation and joint contractures. ClinVar, OMIM #600692
Nemaline Myopathy Dominant-negative mutations (e.g., p.Arg63His) alter thin filament assembly and cause nemaline rod formation in fast skeletal muscle fibers. ClinVar, OMIM #600692
Arthrogryposis Multiplex Congenita, Distal Type 2B Same as DA2B; mutations in TNNT3 cause autosomal dominant distal arthrogryposis with characteristic hand and foot contractures. OMIM #600692

Expression Profile

Tissue Expression
Tissue nTPM level
Skeletal muscle (fast fibers) 150.2 High
Heart 1.8 Low
Brain 0.3 Not detected
Liver 0.1 Not detected
Kidney 0.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
LHCN-M2 (skeletal muscle myotubes) 120.5 Differentiated myotubes
C2C12 (mouse myoblasts) 95.3 After differentiation
HeLa 0.5 Negligible
HEK293 0.3 Negligible
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.187C>T (p.Arg63His) Missense Rare Dominant-negative; causes nemaline myopathy
c.209A>G (p.Asn70Ser) Missense Rare Associated with DA2B; alters calcium sensitivity
c.517G>A (p.Glu173Lys) Missense Rare Associated with DA2B; reduces troponin I binding
c.674C>T (p.Thr225Met) Missense Rare Associated with DA2B; impairs relaxation
Mutation functional classification

Loss of Function (LOF)

No clear loss-of-function mutations reported; TNNT3 is essential for muscle contraction and null alleles are likely lethal.

Gain of Function (GOF)

Not described; mutations typically alter calcium sensitivity rather than gain novel function.

Dominant Negative (DN)

p.Arg63His and other missense mutations act via dominant-negative mechanism, disrupting thin filament regulation and causing nemaline myopathy or distal arthrogryposis.

Pathways

Muscle contraction (Reactome R-HSA-397014)
Cardiac conduction (Reactome R-HSA-5576891)
Striated muscle contraction (KEGG hsa04260)

Protein Summary

Troponin T3 (TnTf) is a 278-amino acid protein (isoform 1) that anchors the troponin complex to tropomyosin on the thin filament of fast skeletal muscle sarcomeres. It contains a hypervariable N-terminal region that undergoes alternative splicing, modulating calcium sensitivity. The protein interacts with troponin I, troponin C, and tropomyosin to regulate actin-myosin cross-bridge formation. Mutations in the N-terminal domain (e.g., p.Arg63His) disrupt thin filament regulation, leading to muscle weakness and contractures.

Related Products

Product name Cat.No. Species Gene ID
TNNT3 Knockout HEK293 Cell Line EDJ-KQ15876 Human 7140 Details Get a Quote
TNNT3 Knockout HeLa Cell Line EDJ-KQ54681 Human 7140 Details Get a Quote
TNNT3 Knockout A-549 Cell Line EDJ-KQ63164 Human 7140 Details Get a Quote
TNNT3 Knockout HCT 116 Cell Line EDJ-KQ71638 Human 7140 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: